New research: Antiviral drug MK-4482 shows promise against Covid-19

MK-4482, delivered orally, is now in human clinical trials. Remdesivir is provided intravenously, making its use primarily limited to clinical settings.

antiviral drug, MK-4482, Coronavirus vaccine, Covid vaccination, India Covid vaccines, India foreign vaccines, SARS-CoV-2 infection, Indian Express

Queue for vaccination against Covid-19 in Mulund, Mumbai. (Express Photo: Deepak Joshi)

An experimental antiviral drug, MK-4482, significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from scientists from the US National Institutes of Health (NIH), and published in the journal Nature Communications.

MK-4482, delivered orally, is now in human clinical trials. Remdesivir is provided intravenously, making its use primarily limited to clinical settings.

The scientists found MK-4482 treatment effective when provided up to 12 hours before or 12 hours after infecting the hamsters with SARS-CoV-2.

These data suggest that MK-4482 treatment potentially could mitigate high-risk exposures to SARS-CoV-2, and might be used to treat established SARS-CoV-2 infection alone or possibly in combination with other agents.

Source: NIH (US)

Mallojula Venugopal Rao alias Sonu and Thippiri Tirupathi alias Devuji

Spate of surrenders later, Maoists get new public liaison who vouches for ‘armed struggle’

India3 hr ago

The banned Communist Party of India (Maoist) has found a new public voice after its ideological head Mallojula Venugopal Rao alias Sonu surrendered along with 60 cadres in Maharashtra earlier this month. According to Telangana intelligence sources, Thippiri Tirupathi alias Devuji, believed to be the current General Secretary of the party, has doubled up as its public face under the pseudonym Abhay

View all shorts

More Explained

Explained An AWS outage took down nearly the entire Internet. What caused it?